We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
-13.55%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$488M
AUM Growth
-$122M
Cap. Flow
-$46M
Cap. Flow %
-9.42%
Top 10 Hldgs %
12.26%
Holding
885
New
278
Increased
177
Reduced
136
Closed
293

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$7.96M
2
MSFT icon
Microsoft
MSFT
+$6.24M
3
EL icon
Estee Lauder
EL
+$5.96M
4
CSCO icon
Cisco
CSCO
+$5.04M
5
WBA
Walgreens Boots Alliance
WBA
+$4.16M

Sector Composition

Rank Sector Weight
1 Technology 24.54%
2 Consumer Discretionary 16.56%
3 Healthcare 14.16%
4 Industrials 11.69%
5 Consumer Staples 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNK
126
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$1.18M 0.24%
74,400
+10,200
+16% +$254K
RH icon
127
RH
RH
$3.41B
$1.17M 0.24%
9,790
+800
+9% +$96.2K
KBR icon
128
KBR
KBR
$4.69B
$1.17M 0.24%
76,970
+48,700
+172% +$911K
CNI icon
129
Canadian National Railway
CNI
$78.1B
$1.16M 0.24%
15,681
+12,500
+393% +$1.04M
SNN icon
130
Smith & Nephew
SNN
$13.1B
$1.16M 0.24%
+30,997
New +$1.12M
VTRS icon
131
Viatris
VTRS
$20.6B
$1.15M 0.24%
+42,100
New +$1.36M
FTNT icon
132
Fortinet
FTNT
$112B
$1.14M 0.23%
81,000
+17,000
+27% +$259K
BJRI icon
133
BJ's Restaurants
BJRI
$1.45B
$1.14M 0.23%
22,472
+1,374
+7% +$82.9K
JNJ icon
134
Johnson & Johnson
JNJ
$644B
$1.13M 0.23%
8,764
-18,436
-68% -$2.57M
ATH
135
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$1.13M 0.23%
28,346
+18,194
+179% +$819K
EFOR
136
Everforth Inc
EFOR
$887M
$1.13M 0.23%
+20,697
New +$1.35M
OSK icon
137
Oshkosh
OSK
$9.62B
$1.12M 0.23%
18,300
+10,700
+141% +$686K
FN icon
138
Fabrinet
FN
$16.8B
$1.11M 0.23%
21,708
+3,000
+16% +$144K
CVNA icon
139
Carvana
CVNA
$45.6B
$1.09M 0.22%
166,500
+73,500
+79% +$619K
AFL icon
140
Aflac
AFL
$64.5B
$1.09M 0.22%
23,859
+3,600
+18% +$160K
GHDX
141
DELISTED
Genomic Health, Inc.
GHDX
$1.09M 0.22%
16,858
+4,400
+35% +$308K
MEDP icon
142
Medpace
MEDP
$16.6B
$1.07M 0.22%
20,258
-16,800
-45% -$922K
SWBI icon
143
Smith & Wesson
SWBI
$662M
$1.07M 0.22%
108,113
+64,139
+146% +$666K
AKAM icon
144
Akamai
AKAM
$16.4B
$1.06M 0.22%
+17,400
New +$1.16M
BRSL
145
Brightstar Lottery PLC
BRSL
$1.93B
$1.06M 0.22%
+72,249
New +$1.19M
DAL icon
146
Delta Air Lines
DAL
$56.5B
$1.04M 0.21%
+20,950
New +$1.14M
WFC icon
147
Wells Fargo
WFC
$264B
$1.04M 0.21%
+22,600
New +$1.16M
FCN icon
148
FTI Consulting
FCN
$4.89B
$1.04M 0.21%
15,600
-12,800
-45% -$860K
J icon
149
Jacobs Solutions
J
$15.9B
$1.04M 0.21%
21,481
-14,745
-41% -$843K
LZB icon
150
La-Z-Boy
LZB
$1.62B
$1.04M 0.21%
37,400
+20,382
+120% +$575K

Similar funds

Bayesian Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Bayesian Capital Management held 885 positions worth $488M, down 20% from $611M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Bayesian Capital Management withdrew a net $46M in Q4 2018, closing 293 positions and reducing 136 holdings. Its most notable exit was Lowe's Companies, an estimated $6.56M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Bayesian Capital Management opened a new position in Nike worth $7.89M.

  • Bayesian Capital Management's largest Q4 2018 buy was Nike: 106,400 shares worth $7.89M.
  • Bayesian Capital Management added most to Microsoft in Q4 2018, an estimated $6.24M increase.
  • Bayesian Capital Management's biggest Q4 2018 reduction was lululemon athletica, cutting an estimated $6.86M.
  • Bayesian Capital Management fully exited Lowe's Companies in Q4 2018, selling an estimated $6.56M.
  • Bayesian Capital Management's ten largest holdings make up 12% of its $488M portfolio in Q4 2018.
  • Bayesian Capital Management opened 278 new positions and closed 293 in Q4 2018.
  • Bayesian Capital Management's portfolio value fell 20% quarter-over-quarter to $488M.

Based on Bayesian Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.